{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T10:26:48Z","timestamp":1781778408961,"version":"3.54.5"},"reference-count":150,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2021,3,27]],"date-time":"2021-03-27T00:00:00Z","timestamp":1616803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Therapeutically controlling chronic progression in multiple sclerosis (MS) remains a major challenge. MS progression is defined as a steady loss of parenchymal and functional integrity of the central nervous system (CNS), occurring independent of relapses or focal, magnetic resonance imaging (MRI)-detectable inflammatory lesions. While it clinically surfaces in primary or secondary progressive MS, it is assumed to be an integral component of MS from the very beginning. The exact mechanisms causing progression are still unknown, although evolving evidence suggests that they may substantially differ from those driving relapse biology. To date, progression is assumed to be caused by an interplay of CNS-resident cells and CNS-trapped hematopoietic cells. On the CNS-resident cell side, microglia that are phenotypically and functionally related to cells of the monocyte\/macrophage lineage may play a key role. Microglia function is highly transformable. Depending on their molecular signature, microglia can trigger neurotoxic pathways leading to neurodegeneration, or alternatively exert important roles in promoting neuroprotection, downregulation of inflammation, and stimulation of repair. Accordingly, to understand and to possibly alter the role of microglial activation during MS disease progression may provide a unique opportunity for the development of suitable, more effective therapeutics. This review focuses on the current understanding of the role of microglia during disease progression of MS and discusses possible targets for therapeutic intervention.<\/jats:p>","DOI":"10.3390\/ijms22073461","type":"journal-article","created":{"date-parts":[[2021,3,28]],"date-time":"2021-03-28T22:09:01Z","timestamp":1616969341000},"page":"3461","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Microglia: The Missing Link to Decipher and Therapeutically Control MS Progression?"],"prefix":"10.3390","volume":"22","author":[{"given":"Anastasia","family":"Geladaris","sequence":"first","affiliation":[{"name":"Department of Neuropathology, University Medical Center, 37075 G\u00f6ttingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darius","family":"H\u00e4usler","sequence":"additional","affiliation":[{"name":"Department of Neuropathology, University Medical Center, 37075 G\u00f6ttingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin S.","family":"Weber","sequence":"additional","affiliation":[{"name":"Department of Neuropathology, University Medical Center, 37075 G\u00f6ttingen, Germany"},{"name":"Department of Neurology, University Medical Center, 37075 G\u00f6ttingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,3,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","article-title":"Defining the clinical course of multiple sclerosis: The 2013 revisions","volume":"83","author":"Lublin","year":"2014","journal-title":"Neurology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/WCO.0b013e328122de1b","article-title":"Combination therapies for multiple sclerosis: Scientific rationale, clinical trials, and clinical practice","volume":"20","author":"Costello","year":"2007","journal-title":"Curr. Opin. Neurol."},{"key":"ref_3","unstructured":"U.S. Food and Drug Administration News Release (2021, January 12). FDA Approves New Drug to Treat Multiple Sclerosis. First Drug Approved for Primary Progressive MS, Available online: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-new-drug-treat-multiple-sclerosis."},{"key":"ref_4","unstructured":"European Medicines Agency Press Release (2021, January 12). New Medicine for Multiple Sclerosis. Available online: https:\/\/www.ema.europa.eu\/en\/news\/new-medicine-multiple-sclerosis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.3389\/fimmu.2019.01564","article-title":"Immunological Aspects of Approved MS Therapeutics","volume":"10","author":"Rommer","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_6","first-page":"527","article-title":"Progressive multiple sclerosis: From pathogenic mechanisms to treatment","volume":"140","author":"Correale","year":"2017","journal-title":"Brain"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/jama.2018.20588","article-title":"Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis","volume":"321","author":"Brown","year":"2019","journal-title":"JAMA"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e574","DOI":"10.1212\/NXI.0000000000000574","article-title":"Natalizumab treatment reduces microglial activation in the white matter of the MS brain","volume":"6","author":"Sucksdorff","year":"2019","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1146\/annurev.neuro.30.051606.094309","article-title":"Axon-glial signaling and the glial support of axon function","volume":"31","author":"Nave","year":"2008","journal-title":"Annu. Rev. Neurosci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1097\/01.jnen.0000235119.52311.16","article-title":"Dysferlin is a new marker for leaky brain blood vessels in multiple sclerosis","volume":"65","author":"Hochmeister","year":"2006","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1742-2094-6-4","article-title":"Differential effects of Th1, monocyte\/macrophage and Th2 cytokine mixtures on early gene expression for molecules associated with metabolism, signaling and regulation in central nervous system mixed glial cell cultures","volume":"6","author":"Lisak","year":"2009","journal-title":"J. Neuroinflamm."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3389\/fneur.2017.00234","article-title":"Primary Progressive Multiple Sclerosis: Putting Together the Puzzle","volume":"8","author":"Abdelhak","year":"2017","journal-title":"Front. Neurol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1056\/NEJMoa1100648","article-title":"Inflammatory cortical demyelination in early multiple sclerosis","volume":"365","author":"Lucchinetti","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1038\/s41467-018-07053-9","article-title":"Tissue-resident memory T cells populate the human brain","volume":"9","author":"Smolders","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/acn3.783","article-title":"Communication of CD8(+) T cells with mononuclear phagocytes in multiple sclerosis","volume":"6","author":"Held","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1093\/brain\/awy151","article-title":"The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+ T lymphocytes and B cells","volume":"141","author":"Saji","year":"2018","journal-title":"Brain"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3389\/fimmu.2020.00137","article-title":"Editorial: Multiple Sclerosis\u2014From Bench to Bedside: Currents Insights into Pathophysiological Concepts and Their Potential Impact on Patients","volume":"11","author":"Rommer","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/brain\/awm038","article-title":"Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology","volume":"130","author":"Magliozzi","year":"2007","journal-title":"Brain"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1084\/jem.20041674","article-title":"BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma","volume":"201","author":"Krumbholz","year":"2005","journal-title":"J. Exp. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.bbadis.2015.09.018","article-title":"Oxidative stress and its impact on neurons and glia in multiple sclerosis lesions","volume":"1862","author":"Lassmann","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0166-2236(88)90110-5","article-title":"Macrophages and microglia in the nervous system","volume":"11","author":"Perry","year":"1988","journal-title":"Trends Neurosci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/0166-2236(96)10049-7","article-title":"Microglia: A sensor for pathological events in the CNS","volume":"19","author":"Kreutzberg","year":"1996","journal-title":"Trends Neurosci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fncel.2013.00045","article-title":"Origin and differentiation of microglia","volume":"7","author":"Ginhoux","year":"2013","journal-title":"Front. Cell Neurosci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1152\/physrev.00011.2010","article-title":"Physiology of microglia","volume":"91","author":"Kettenmann","year":"2011","journal-title":"Physiol. Rev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2741\/2692","article-title":"Macrophage activation and polarization","volume":"13","author":"Martinez","year":"2008","journal-title":"Front. Biosci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bbi.2013.02.005","article-title":"Characterization of phenotype markers and neuronotoxic potential of polarised primary microglia in vitro","volume":"32","author":"Chhor","year":"2013","journal-title":"Brain Behav. Immun."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1126\/science.1227901","article-title":"Microglia: Scapegoat, saboteur, or something else?","volume":"339","author":"Aguzzi","year":"2013","journal-title":"Science"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.3389\/fimmu.2017.01905","article-title":"Neuroinflammation: Microglia and T Cells Get Ready to Tango","volume":"8","author":"Schetters","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.4049\/jimmunol.141.7.2407","article-title":"Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production","volume":"141","author":"Ding","year":"1988","journal-title":"J. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/0014-5793(87)80305-8","article-title":"Production of superoxide anions by a CNS macrophage, the microglia","volume":"223","author":"Colton","year":"1987","journal-title":"FEBS Lett."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1093\/brain\/awp070","article-title":"The relation between inflammation and neurodegeneration in multiple sclerosis brains","volume":"132","author":"Frischer","year":"2009","journal-title":"Brain"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","article-title":"Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination","volume":"47","author":"Lucchinetti","year":"2000","journal-title":"Ann. Neurol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00401-016-1653-y","article-title":"An updated histological classification system for multiple sclerosis lesions","volume":"133","author":"Kuhlmann","year":"2017","journal-title":"Acta Neuropathol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1093\/brain\/awx113","article-title":"Loss of \u2019homeostatic\u2019 microglia and patterns of their activation in active multiple sclerosis","volume":"140","author":"Zrzavy","year":"2017","journal-title":"Brain"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/brain\/124.8.1635","article-title":"Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: Increased yield of active demyelinating and (p)reactive lesions","volume":"124","author":"Bergers","year":"2001","journal-title":"Brain"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/s41467-019-08976-7","article-title":"G.; Helder, B.; Tas, S.W.; Schultze, J.L.; et al. Transcriptional profiling of human microglia reveals grey-white matter heterogeneity and multiple sclerosis-associated changes","volume":"10","author":"Ulas","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.nbd.2014.01.018","article-title":"Microglia activation in multiple sclerosis black holes predicts outcome in progressive patients: An in vivo [(11)C](R)-PK11195-PET pilot study","volume":"65","author":"Giannetti","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s40478-020-01010-8","article-title":"C.J.; Kunkel, D.; et al. Single-cell mass cytometry reveals complex myeloid cell composition in active lesions of progressive multiple sclerosis","volume":"8","author":"Bottcher","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"O\u2019Loughlin, E., Madore, C., Lassmann, H., and Butovsky, O. (2018). Microglial Phenotypes and Functions in Multiple Sclerosis. Cold Spring Harb. Perspect. Med., 8.","DOI":"10.1101\/cshperspect.a028993"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s41586-018-0119-x","article-title":"Microglial control of astrocytes in response to microbial metabolites","volume":"557","author":"Rothhammer","year":"2018","journal-title":"Nature"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1093\/brain\/aws012","article-title":"NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury","volume":"135","author":"Fischer","year":"2012","journal-title":"Brain"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/ana.22109","article-title":"Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis","volume":"69","author":"Campbell","year":"2011","journal-title":"Ann. Neurol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/brain\/awp046","article-title":"Mitochondrial changes within axons in multiple sclerosis","volume":"132","author":"Mahad","year":"2009","journal-title":"Brain"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/ana.23974","article-title":"Iron and neurodegeneration in the multiple sclerosis brain","volume":"74","author":"Hametner","year":"2013","journal-title":"Ann. Neurol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Karamita, M., Barnum, C., Mobius, W., Tansey, M.G., Szymkowski, D.E., Lassmann, H., and Probert, L. (2017). Therapeutic inhibition of soluble brain TNF promotes remyelination by increasing myelin phagocytosis by microglia. JCI Insight, 2.","DOI":"10.1172\/jci.insight.87455"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1084\/jem.20141656","article-title":"Inefficient clearance of myelin debris by microglia impairs remyelinating processes","volume":"212","author":"Lampron","year":"2015","journal-title":"J. Exp. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1084\/jem.20132477","article-title":"Differential roles of microglia and monocytes in the inflamed central nervous system","volume":"211","author":"Yamasaki","year":"2014","journal-title":"J. Exp. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1172\/JCI77983","article-title":"TREM2 sustains microglial expansion during aging and response to demyelination","volume":"125","author":"Poliani","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00401-013-1112-y","article-title":"Insufficient OPC migration into demyelinated lesions is a cause of poor remyelination in MS and mouse models","volume":"125","author":"Boyd","year":"2013","journal-title":"Acta Neuropathol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"a020594","DOI":"10.1101\/cshperspect.a020594","article-title":"Glia Disease and Repair-Remyelination","volume":"7","author":"Franklin","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/nn.3469","article-title":"M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination","volume":"16","author":"Miron","year":"2013","journal-title":"Nat. Neurosci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.immuni.2012.05.023","article-title":"Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration","volume":"37","author":"Starossom","year":"2012","journal-title":"Immunity"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"6350","DOI":"10.1523\/JNEUROSCI.2468-14.2015","article-title":"MSX3 Switches Microglia Polarization and Protects from Inflammation-Induced Demyelination","volume":"35","author":"Yu","year":"2015","journal-title":"J. Neurosci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/s41593-019-0418-z","article-title":"Central nervous system regeneration is driven by microglia necroptosis and repopulation","volume":"22","author":"Lloyd","year":"2019","journal-title":"Nat. Neurosci."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1016\/j.celrep.2015.02.051","article-title":"Activation of necroptosis in multiple sclerosis","volume":"10","author":"Ofengeim","year":"2015","journal-title":"Cell Rep."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.biopha.2017.09.110","article-title":"Anti-encephalitogenic effects of ethyl pyruvate are reflected in the central nervous system and the gut","volume":"96","author":"Djedovic","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3389\/fneur.2018.00181","article-title":"Evaluation of Microglial Activation in Multiple Sclerosis Patients Using Positron Emission Tomography","volume":"9","author":"Airas","year":"2018","journal-title":"Front. Neurol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/ana.24791","article-title":"Neuroinflammatory component of gray matter pathology in multiple sclerosis","volume":"80","author":"Herranz","year":"2016","journal-title":"Ann. Neurol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"939","DOI":"10.2967\/jnumed.113.131698","article-title":"In Vivo Detection of Diffuse Inflammation in Secondary Progressive Multiple Sclerosis Using PET Imaging and the Radioligand (1)(1)C-PK11195","volume":"55","author":"Rissanen","year":"2014","journal-title":"J. Nucl. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1093\/brain\/awaa275","article-title":"Brain TSPO-PET predicts later disease progression independent of relapses in multiple sclerosis","volume":"143","author":"Sucksdorff","year":"2020","journal-title":"Brain"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1093\/brain\/awn217","article-title":"Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation","volume":"131","author":"Piccio","year":"2008","journal-title":"Brain"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1177\/1352458515624558","article-title":"Soluble TREM-2 in cerebrospinal fluid from patients with multiple sclerosis treated with natalizumab or mitoxantrone","volume":"22","author":"Ohrfelt","year":"2016","journal-title":"Mult. Scler."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/nrn.2015.29","article-title":"Extracellular vesicles round off communication in the nervous system","volume":"17","author":"Budnik","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/ana.23627","article-title":"Myeloid microvesicles are a marker and therapeutic target for neuroinflammation","volume":"72","author":"Verderio","year":"2012","journal-title":"Ann. Neurol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJMoa1606468","article-title":"Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis","volume":"376","author":"Montalban","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/ana.21867","article-title":"Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial","volume":"66","author":"Hawker","year":"2009","journal-title":"Ann. Neurol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nature02284","article-title":"Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1","volume":"427","author":"Matloubian","year":"2004","journal-title":"Nature"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0140-6736(18)30475-6","article-title":"Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): A double-blind, randomised, phase 3 study","volume":"391","author":"Kappos","year":"2018","journal-title":"Lancet"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0140-6736(15)01314-8","article-title":"Oral fingolimod in primary progressive multiple sclerosis (INFORMS): A phase 3, randomised, double-blind, placebo-controlled trial","volume":"387","author":"Lublin","year":"2016","journal-title":"Lancet"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Kipp, M. (2020). Does Siponimod Exert Direct Effects in the Central Nervous System?. Cells, 9.","DOI":"10.3390\/cells9081771"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1124\/jpet.107.127183","article-title":"Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: Consequences for mode of action in multiple sclerosis","volume":"323","author":"Foster","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_73","first-page":"308","article-title":"Siponimod treatment leads to a dose-dependent reduction of EAE severity associated with downregulation of microglial activity","volume":"26","author":"Husseini","year":"2020","journal-title":"MSVirtual"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12974-016-0494-x","article-title":"The dual S1PR1\/S1PR5 drug BAF312 (Siponimod) attenuates demyelination in organotypic slice cultures","volume":"13","author":"Schubart","year":"2016","journal-title":"J. Neuroinflamm."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12974-016-0686-4","article-title":"Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis","volume":"13","author":"Gentile","year":"2016","journal-title":"J. Neuroinflamm."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3389\/fimmu.2020.00635","article-title":"Siponimod (BAF312) Activates Nrf2 While Hampering NFkappaB in Human Astrocytes, and Protects From Astrocyte-Induced Neurodegeneration","volume":"11","author":"Colombo","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1002\/glia.23058","article-title":"Activation of the astrocytic Nrf2\/ARE system ameliorates the formation of demyelinating lesions in a multiple sclerosis animal model","volume":"64","author":"Draheim","year":"2016","journal-title":"Glia"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1177\/1352458517721355","article-title":"The Xenopus tadpole: An in vivo model to screen drugs favoring remyelination","volume":"24","author":"Mannioui","year":"2018","journal-title":"Mult. Scler."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrc3702","article-title":"Targeting Bruton\u2019s tyrosine kinase in B cell malignancies","volume":"14","author":"Hendriks","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"ref_80","first-page":"243","article-title":"Bruton\u2019s tyrosine kinase\u2014An integral protein of B cell development that also has an essential role in the innate immune system","volume":"95","year":"2014","journal-title":"J. Leukoc. Biol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1056\/NEJMoa1901981","article-title":"Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple Sclerosis","volume":"380","author":"Montalban","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_82","first-page":"220","article-title":"Examination of fenebrutinib, a highly selective BTKi, on disease progression of multiple sclerosis","volume":"26","author":"Gheen","year":"2020","journal-title":"MSVirtual"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"37651","DOI":"10.1074\/jbc.M311985200","article-title":"Tec kinases mediate sustained calcium influx via site-specific tyrosine phosphorylation of the phospholipase Cgamma Src homology 2-Src homology 3 linker","volume":"279","author":"Humphries","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.clim.2017.07.008","article-title":"X-Linked Agammaglobulinaemia: Outcomes in the modern era","volume":"183","author":"Shillitoe","year":"2017","journal-title":"Clin Immunol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12943-018-0779-z","article-title":"Role of Bruton\u2019s tyrosine kinase in B cells and malignancies","volume":"17","author":"Dammeijer","year":"2018","journal-title":"Mol. Cancer"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3233\/BPL-200100","article-title":"Bruton\u2019s Tyrosine Kinase Inhibition Promotes Myelin Repair","volume":"5","author":"Martin","year":"2020","journal-title":"Brain Plasticity"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s11481-019-09839-0","article-title":"Inhibition of Bruton\u2019s Tyrosine Kinase Modulates Microglial Phagocytosis: Therapeutic Implications for Alzheimer\u2019s Disease","volume":"14","author":"Keaney","year":"2019","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref_88","first-page":"270","article-title":"Decoding Bruton\u2019s tyrosine kinase signalling in neuroinflammation","volume":"26","author":"Glendenning","year":"2020","journal-title":"MSVirtual"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/s12974-018-1308-0","article-title":"Ibrutinib suppresses LPS-induced neuroinflammatory responses in BV2 microglial cells and wild-type mice","volume":"15","author":"Nam","year":"2018","journal-title":"J. Neuroinflamm."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/glia.22803","article-title":"Tyrphostin AG126 exerts neuroprotection in CNS inflammation by a dual mechanism","volume":"63","author":"Menzfeld","year":"2015","journal-title":"Glia"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1002\/jnr.20839","article-title":"CCL5 evokes calcium signals in microglia through a kinase-, phosphoinositide-, and nucleotide-dependent mechanism","volume":"83","author":"Shideman","year":"2006","journal-title":"J. Neurosci. Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1126\/science.1154370","article-title":"Discovery of a cytokine and its receptor by functional screening of the extracellular proteome","volume":"320","author":"Lin","year":"2008","journal-title":"Science"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1016\/S0021-9258(17)40265-1","article-title":"Factors regulating macrophage production and growth. Purification and some properties of the colony stimulating factor from medium conditioned by mouse L cells","volume":"252","author":"Stanley","year":"1977","journal-title":"J. Biol. Chem."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Stanley, E.R., and Chitu, V. (2014). CSF-1 receptor signaling in myeloid cells. Cold Spring Harb. Perspect. Biol., 6.","DOI":"10.1101\/cshperspect.a021857"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.neuron.2014.02.040","article-title":"Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain","volume":"82","author":"Elmore","year":"2014","journal-title":"Neuron"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.4049\/jimmunol.1701488","article-title":"Csf1r-mApple Transgene Expression and Ligand Binding In Vivo Reveal Dynamics of CSF1R Expression within the Mononuclear Phagocyte System","volume":"200","author":"Hawley","year":"2018","journal-title":"J. Immunol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.tins.2016.03.005","article-title":"Emerging Roles for CSF-1 Receptor and its Ligands in the Nervous System","volume":"39","author":"Chitu","year":"2016","journal-title":"Trends Neurosci."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/ene.13125","article-title":"Clinical and genetic characterization of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia associated with CSF1R mutation","volume":"24","author":"Konno","year":"2017","journal-title":"Eur. J. Neurol."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Erblich, B., Zhu, L., Etgen, A.M., Dobrenis, K., and Pollard, J.W. (2011). Absence of colony stimulation factor-1 receptor results in loss of microglia, disrupted brain development and olfactory deficits. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0026317"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/s41419-020-03084-7","article-title":"CSF1R signaling is a regulator of pathogenesis in progressive MS","volume":"11","author":"Hagan","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.expneurol.2018.05.021","article-title":"Csf1R inhibition attenuates experimental autoimmune encephalomyelitis and promotes recovery","volume":"307","author":"Nissen","year":"2018","journal-title":"Exp. Neurol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"23336","DOI":"10.1073\/pnas.1922788117","article-title":"CSF1R inhibition by a small-molecule inhibitor is not microglia specific; affecting hematopoiesis and the function of macrophages","volume":"117","author":"Lei","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"10576","DOI":"10.1002\/jcb.28344","article-title":"Effect of the CSF1R inhibitor PLX3397 on remyelination of corpus callosum in a cuprizone-induced demyelination mouse model","volume":"120","author":"Tahmasebi","year":"2019","journal-title":"J. Cell Biochem."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40478-018-0510-8","article-title":"Brain region-specific enhancement of remyelination and prevention of demyelination by the CSF1R kinase inhibitor BLZ945","volume":"6","author":"Beckmann","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1084\/jem.20120412","article-title":"Colony-stimulating factor 1 receptor (CSF1R) signaling in injured neurons facilitates protection and survival","volume":"210","author":"Luo","year":"2013","journal-title":"J. Exp. Med."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/s41582-018-0072-1","article-title":"TREM2\u2014A key player in microglial biology and Alzheimer disease","volume":"14","author":"Ulland","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1086\/342259","article-title":"Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype","volume":"71","author":"Paloneva","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1211103","article-title":"Variant of TREM2 associated with the risk of Alzheimer\u2019s disease","volume":"368","author":"Jonsson","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"726.e11","DOI":"10.1016\/j.neurobiolaging.2013.09.009","article-title":"Investigating the role of rare heterozygous TREM2 variants in Alzheimer\u2019s disease and frontotemporal dementia","volume":"35","author":"Cuyvers","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s004010000284","article-title":"Local distribution of microglia in the normal adult human central nervous system differs by up to one order of magnitude","volume":"101","author":"Mittelbronn","year":"2001","journal-title":"Acta Neuropathol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1016\/j.neurobiolaging.2013.05.001","article-title":"Insights into TREM2 biology by network analysis of human brain gene expression data","volume":"34","author":"Forabosco","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"33027","DOI":"10.1074\/jbc.M113.517540","article-title":"Sequential proteolytic processing of the triggering receptor expressed on myeloid cells-2 (TREM2) protein by ectodomain shedding and gamma-secretase-dependent intramembranous cleavage","volume":"288","author":"Wunderlich","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1084\/jem.20041611","article-title":"Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2","volume":"201","author":"Takahashi","year":"2005","journal-title":"J. Exp. Med."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Takahashi, K., Prinz, M., Stagi, M., Chechneva, O., and Neumann, H. (2007). TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis. PLoS Med., 4.","DOI":"10.1371\/journal.pmed.0040124"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00401-020-02193-z","article-title":"TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis","volume":"140","author":"Cignarella","year":"2020","journal-title":"Acta Neuropathol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1084\/jem.194.8.1111","article-title":"A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells","volume":"194","author":"Bouchon","year":"2001","journal-title":"J. Exp. Med."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"11138","DOI":"10.1523\/JNEUROSCI.1238-16.2016","article-title":"TREM2\/DAP12 Signal Elicits Proinflammatory Response in Microglia and Exacerbates Neuropathic Pain","volume":"36","author":"Kobayashi","year":"2016","journal-title":"J. Neurosci."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"10896","DOI":"10.1073\/pnas.95.18.10896","article-title":"Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia","volume":"95","author":"Harrison","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0002-9440(10)64034-5","article-title":"The transmembrane form of the CX3CL1 chemokine fractalkine is expressed predominantly by epithelial cells in vivo","volume":"158","author":"Lucas","year":"2001","journal-title":"Am. J. Pathol"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3389\/fncel.2014.00229","article-title":"Modulating neurotoxicity through CX3CL1\/CX3CR1 signaling","volume":"8","author":"Limatola","year":"2014","journal-title":"Front. Cell Neurosci."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/(SICI)1098-1136(20000215)29:4<305::AID-GLIA2>3.0.CO;2-V","article-title":"Fractalkine modulates TNF-alpha secretion and neurotoxicity induced by microglial activation","volume":"29","author":"Zujovic","year":"2000","journal-title":"Glia"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0006-8993(03)02867-1","article-title":"Production and neuroprotective functions of fractalkine in the central nervous system","volume":"979","author":"Mizuno","year":"2003","journal-title":"Brain Res."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1111\/ejn.14879","article-title":"Functional analysis of CX3CR1 in human induced pluripotent stem (iPS) cell-derived microglia-like cells","volume":"52","author":"Murai","year":"2020","journal-title":"Eur. J. Neurosci."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.2353\/ajpath.2010.100265","article-title":"CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer\u2019s disease mouse models","volume":"177","author":"Lee","year":"2010","journal-title":"Am. J. Pathol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"17091","DOI":"10.1523\/JNEUROSCI.4403-10.2010","article-title":"CX3CR1 in microglia regulates brain amyloid deposition through selective protofibrillar amyloid-beta phagocytosis","volume":"30","author":"Liu","year":"2010","journal-title":"J. Neurosci."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1742-2094-2-17","article-title":"CX3CL1 (fractalkine) and CX3CR1 expression in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis: Kinetics and cellular origin","volume":"2","author":"Sunnemark","year":"2005","journal-title":"J. Neuroinflamm."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/npp.2010.26","article-title":"Adenosine A1 receptors and microglial cells mediate CX3CL1-induced protection of hippocampal neurons against Glu-induced death","volume":"35","author":"Lauro","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"16327","DOI":"10.1523\/JNEUROSCI.3611-11.2011","article-title":"CX3CL1 is neuroprotective in permanent focal cerebral ischemia in rodents","volume":"31","author":"Cipriani","year":"2011","journal-title":"J. Neurosci."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jneuroim.2013.07.020","article-title":"CX3CL1 protects neurons against excitotoxicity enhancing GLT-1 activity on astrocytes","volume":"263","author":"Catalano","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.4049\/jimmunol.1300040","article-title":"Regulation of adaptive immunity by the fractalkine receptor during autoimmune inflammation","volume":"191","author":"Garcia","year":"2013","journal-title":"J. Immunol."},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Mecca, C., Giambanco, I., Donato, R., and Arcuri, C. (2018). Microglia and Aging: The Role of the TREM2-DAP12 and CX3CL1-CX3CR1 Axes. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19010318"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0092-8674(00)80438-9","article-title":"Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion","volume":"91","author":"Imai","year":"1997","journal-title":"Cell"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1096\/fj.05-3832fje","article-title":"Frequency of blood CX3CR1-positive natural killer cells correlates with disease activity in multiple sclerosis patients","volume":"19","author":"Weber","year":"2005","journal-title":"FASEB J."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"5409","DOI":"10.1073\/pnas.1316510111","article-title":"Pharmacological inhibition of the chemokine receptor CX3CR1 attenuates disease in a chronic-relapsing rat model for multiple sclerosis","volume":"111","author":"Jureus","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/nature01786","article-title":"P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury","volume":"424","author":"Tsuda","year":"2003","journal-title":"Nature"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/glia.20160","article-title":"Metabotropic P2 receptor activation regulates oligodendrocyte progenitor migration and development","volume":"50","author":"Agresti","year":"2005","journal-title":"Glia"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.alcohol.2017.09.004","article-title":"Reduced expression of purinergic P2X4 receptors increases voluntary ethanol intake in C57BL\/6J mice","volume":"68","author":"Khoja","year":"2018","journal-title":"Alcohol"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1038\/npp.2013.98","article-title":"Sociocommunicative and sensorimotor impairments in male P2X4-deficient mice","volume":"38","author":"Wyatt","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/glia.22596","article-title":"P2X4 receptors control the fate and survival of activated microglia","volume":"62","author":"Domercq","year":"2014","journal-title":"Glia"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1038\/ncomms4771","article-title":"Transcription factor IRF5 drives P2X4R+-reactive microglia gating neuropathic pain","volume":"5","author":"Masuda","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/ni.1990","article-title":"IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses","volume":"12","author":"Krausgruber","year":"2011","journal-title":"Nat. Immunol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/jnr.20181","article-title":"BDNF overexpression produces a long-term increase in myelin formation in the peripheral nervous system","volume":"77","author":"Tolwani","year":"2004","journal-title":"J. Neurosci. Res."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/glia.23527","article-title":"Overexpression of P2X4 receptor in Schwann cells promotes motor and sensory functional recovery and remyelination via BDNF secretion after nerve injury","volume":"67","author":"Su","year":"2019","journal-title":"Glia"},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Zabala, A., Vazquez-Villoldo, N., Rissiek, B., Gejo, J., Martin, A., Palomino, A., Perez-Samartin, A., Pulagam, K.R., Lukowiak, M., and Capetillo-Zarate, E. (2018). P2X4 receptor controls microglia activation and favors remyelination in autoimmune encephalitis. EMBO Mol. Med., 10.","DOI":"10.15252\/emmm.201708743"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fphar.2017.00048","article-title":"Blockade of P2X4 Receptors Inhibits Neuropathic Pain-Related Behavior by Preventing MMP-9 Activation and, Consequently, Pronociceptive Interleukin Release in a Rat Model","volume":"8","author":"Jurga","year":"2017","journal-title":"Front. Pharmacol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.coph.2019.03.010","article-title":"Targeting P2X4 and P2X7 receptors in multiple sclerosis","volume":"47","author":"Domercq","year":"2019","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1172\/JCI120972","article-title":"Purinergic P2X4 receptors and mitochondrial ATP production regulate T cell migration","volume":"128","author":"Ledderose","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"a020412","DOI":"10.1101\/cshperspect.a020412","article-title":"The blood-brain barrier","volume":"7","author":"Daneman","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.2174\/1381612822666151221150733","article-title":"Evolving Drug Delivery Strategies to Overcome the Blood Brain Barrier","volume":"22","author":"Hersh","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"030902","DOI":"10.1063\/5.0013178","article-title":"Microglia-targeting nanotherapeutics for neurodegenerative diseases","volume":"4","author":"Zhao","year":"2020","journal-title":"APL Bioeng."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/7\/3461\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T14:10:11Z","timestamp":1760364611000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/7\/3461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,27]]},"references-count":150,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,4]]}},"alternative-id":["ijms22073461"],"URL":"https:\/\/doi.org\/10.3390\/ijms22073461","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,27]]}}}